Catalyst Excel & Advance

Catalyst Excel & Advance appears to have been a life sciences advisory firm rather than a drug developer, manufacturer, or commercial-stage biopharma company. Public references describe it as providing operational guidance to senior executives launching new pharmaceutical and biopharmaceutical companies. The firm is most notably referenced in executive biographies for Esther M. Alegria, who served as President and Senior Executive Advisor from 2016 to 2020. Based on the limited public footprint, the business seems to have operated as a specialized strategic and operational consultancy focused on emerging biopharma company formation and launch support. There is no clear evidence of an in-house therapeutic pipeline, proprietary platform, public listing, or acquisition.